Overview

Convolvulus pluricaulis is a small, creeping perennial herb of the Convolvulaceae (morning glory) family, native to the Indian subcontinent. Known as Shankhpushpi in Ayurvedic medicine, it is classified as a medhya rasayana—an elite category of herbs specifically designated for enhancing intellect, memory, and cognitive function. The entire plant is used medicinally, and it has been a cornerstone of traditional Indian cognitive health practices for centuries. Its name derives from the Sanskrit words "shankha" (conch shell) and "pushpi" (flower), referring to its conch-shaped blossoms.

The bioactive profile of Convolvulus pluricaulis includes flavonoids, coumarins, alkaloids (shankhpushpine), triterpenoids, and glycosides. Preclinical research has demonstrated multiple neuropharmacological effects, including anxiolytic activity comparable to diazepam in animal models, antidepressant effects, and significant improvements in memory acquisition and retention. The mechanisms appear to involve modulation of acetylcholinesterase activity, enhancement of GABAergic neurotransmission, and potent antioxidant protection against oxidative stress in brain tissue. Some studies also suggest neuroprotective effects against glutamate excitotoxicity and heavy metal-induced neurotoxicity.

In traditional practice, Shankhpushpi is typically consumed as a whole-plant powder, juice, or decoction, often combined with other Ayurvedic brain tonics such as Bacopa monnieri (Brahmi) and Centella asiatica (Gotu Kola). While the traditional evidence base is extensive and preclinical studies are promising, rigorous human clinical trials remain limited. Available human studies suggest benefits for cognitive function and stress reduction, but larger, well-controlled trials are needed to establish definitive clinical efficacy. The herb is generally well-tolerated and is available in standardized extract forms in the supplement market.

Mechanism of Action

Shankhpushpi — GABAergic & Cholinergic Dual Modulation

Convolvulus pluricaulis (Shankhpushpi) is a perennial herb from Convolvulaceae containing shankhpushpine (a tropane-like alkaloid), scopoletin (a coumarin), beta-sitosterol, and microphyllic acid as primary bioactive constituents. The anxiolytic and nootropic effects are mediated primarily through GABAergic modulation — scopoletin and the total alkaloid fraction enhance GABA-A receptor chloride conductance by binding at or near the benzodiazepine modulatory site, increasing chloride influx frequency without altering channel open time. This produces dose-dependent anxiolysis comparable to diazepam at 200-400 mg/kg in the elevated plus maze without significant motor impairment (PMID: 11498727).

Acetylcholinesterase Inhibition & Memory Enhancement

The ethanolic extract of Convolvulus pluricaulis inhibits acetylcholinesterase (AChE) with an IC50 of approximately 150 mcg/mL, increasing synaptic acetylcholine in hippocampal and cortical regions. This enhances memory consolidation and retrieval in scopolamine-induced amnesia models, restoring step-down latency in passive avoidance paradigms. The extract also upregulates muscarinic M1 receptor expression in the hippocampus, amplifying cholinergic signaling for spatial and contextual memory processing (PMID: 17430636).

Neuroprotection via Antioxidant & Anti-Excitotoxic Mechanisms

Convolvulus pluricaulis reduces glutamate-mediated excitotoxicity by modulating NMDA receptor activation — the extract attenuates calcium influx through NMDA channels, preventing calpain activation, mitochondrial membrane depolarization, and subsequent cytochrome c release. Concurrently, the flavonoid fraction (kaempferol, quercetin glycosides) activates Nrf2/ARE signaling, inducing superoxide dismutase (SOD), catalase, and glutathione peroxidase expression in hippocampal neurons (PMID: 22178180).

Thyroid Modulation & Adaptogenic Properties

Convolvulus pluricaulis demonstrates antithyroid activity, reducing serum T3 and T4 levels by inhibiting thyroid peroxidase (TPO)-mediated iodination and coupling reactions. This contributes to its traditional use as a calming herb by reducing sympathetic nervous system activation driven by excess thyroid hormones (PMID: 15478203).

Reconstitution Calculator

Research

Safety Profile

Safety Profile: Convolvulus Pluricaulis (Shankhpushpi)

Common Side Effects

• Mild gastrointestinal discomfort: nausea, loose stools, and occasional stomach upset, especially with alcoholic (tincture) preparations
• Drowsiness and mild sedation (traditional use as a brain tonic includes anxiolytic properties)
• Reduced appetite at higher doses
• Mild headache during initial supplementation
• Hypotension: mild blood pressure reduction due to smooth muscle relaxant properties

Serious Adverse Effects

• Thyroid suppression: multiple animal studies demonstrate that Convolvulus pluricaulis decreases serum T3 and T4 levels while increasing TSH; may exacerbate hypothyroidism or interfere with thyroid hormone therapy
• Hepatotoxicity: isolated case reports and animal studies suggest potential liver injury at high doses or with prolonged use; mechanism unclear but may involve hepatic CYP enzyme modulation
• Excessive sedation: at higher-than-traditional doses, CNS depression may impair driving and operating machinery
• Hypoglycemia: animal studies show blood glucose–lowering effects; risk when combined with antidiabetic medications
• Very limited human clinical data: most safety information derives from Ayurvedic traditional use and animal pharmacological studies; rigorous clinical trials in humans are scarce

Contraindications

• Hypothyroidism or subclinical hypothyroidism (thyroid-suppressive effects documented in animal studies)
• Current thyroid hormone replacement therapy (may reduce efficacy of levothyroxine)
• Pregnancy and lactation: traditionally contraindicated; some Ayurvedic texts suggest uterotonic effects; no modern safety data
• Known allergy to Convolvulaceae family plants (morning glory, bindweed)
• Severe hepatic impairment

Drug Interactions

• Thyroid hormones (levothyroxine, liothyronine): Shankhpushpi may reduce thyroid hormone levels and counteract replacement therapy; documented in pharmacological studies; separate administration is insufficient—avoid combination or monitor closely
• CNS depressants (benzodiazepines, barbiturates, opioids, alcohol): additive sedation; increased risk of respiratory depression and cognitive impairment
• Antidiabetic medications (insulin, metformin, sulfonylureas): additive hypoglycemic effect; blood glucose monitoring recommended
• Antihypertensives: additive blood pressure–lowering; risk of orthostatic hypotension
• Antiepileptic drugs (phenytoin, valproic acid): traditional use includes anticonvulsant properties; may alter seizure threshold or drug metabolism
• Phenytoin specifically: one study showed Shankhpushpi reduced phenytoin bioavailability by ~50%, potentially leading to seizure breakthrough

Population-Specific Considerations

• Cognitive enhancement / students: most traditional use case in Ayurveda; water-based extracts (kwath) at 250–500 mg standardized extract or 3–5 g powder are traditional doses; sedation may impair rather than help acute cognitive tasks
• Anxiety disorders: anxiolytic effects are documented in animal models; may complement conventional therapy but should not replace evidence-based treatments
• Thyroid patients: strongly advise thyroid function monitoring (TSH, free T3, free T4) before and during use; consider avoiding entirely in established hypothyroidism
• Children: used traditionally in Ayurveda for pediatric cognitive development (Medhya Rasayana); however, no modern safety studies exist; use only under practitioner guidance
• Elderly: increased sensitivity to sedative and hypotensive effects; start at lowest traditional dose; fall risk assessment recommended
• Epilepsy patients: avoid concurrent use with phenytoin specifically; interaction with other AEDs is less characterized but caution warranted

Pharmacokinetic Profile